C08L25/08

Phase change material for thermal therapy and delivery of active ingredients
11707556 · 2023-07-25 · ·

A method of manufacturing a therapeutic material incorporating a soft thermoformable elastomer with a phase change material exhibiting high latent heat of fusion. The compound provides elasticity, softness, formability, and heat over an extended duration and to facilitate prolonged skin contact at elevated temperatures. Used in combination with active ingredients the increased temperature and formability provides enhanced transdermal delivery through the skin. Thermoplastic elastomers may be manufactured by mixing together plasticizing oil, a triblock copolymer, a paraffinic substance and one or more additives, e.g., an antioxidant, an antimicrobial agent, and/or other additives to form a mixture which melted then cooled into the thermoplastic elastomer. During cooling, the thermoplastic elastomer may be molded or otherwise formed into any number of articles including, but not limited to, prosthetic liners, prosthetic sleeves, external breast prostheses, breast enhancement bladders, masks, wound dressing sheets, wound dressing pads, socks, gloves, malleolus pads, metatarsal pads, shoe insoles, urinary catheters, vascular catheters, and balloons for medical catheters both vascular as well as urinary. Active ingredients are preferably added to the cooling thermoplastic elastomer when the temperature is below 100° F. to prevent heat degradation and/or breakdown of vital proteins.

POLYMERIC COMPOSITION, ITS METHOD OF PREPARATION, ITS USE AND OBJECT COMPRISING IT

A process for increasing the chemical resistance of a polymeric composition is provided. The method includes a step of blending: a) the (meth)acrylic polymer AP1 and b) a copolymer CP1. The copolymer CP1 includes at least 41 wt % of vinyl aromatic monomer units by weight of the copolymer CPI. The polymeric composition includes at least 5 wt % of the copolymer CP1, by weight of the polymeric composition. A chemical resistance of the polymeric composition is better than a chemical resistance of the (meth)acrylic polymer AP1 without CP1. Chemical resistance is measured by a time to crack at 120° C. when subjected to an outer radius bending strain of 75% and wetted with a cloth soaked in isopropanol 99%.

Patient support formed from an elastomeric composition including a polymer blend of seeps copolymers

This disclosure provides a person support formed from an elastomeric composition. The elastomeric composition includes a polymer blend with the polymer blend consisting essentially of a first and second SEEPS copolymer. The first and second SEEPS copolymers are present in the polymer blend in an amount of from 75 to 95 percent by weight and 5 to 25 percent by weight, respectively, based on the total weight of the polymer blend. In addition, the sum of the first and second SEEPS copolymers in the polymer blend is 100 percent by weight. The first and second SEEPS copolymers have a weight average molecular weight of weight of at least 200,000 and 125,000 to 175,000, respectively. The disclosure also provides a patient support for supporting a patient with the patient support formed from the elastomeric composition.

Patient support formed from an elastomeric composition including a polymer blend of seeps copolymers

This disclosure provides a person support formed from an elastomeric composition. The elastomeric composition includes a polymer blend with the polymer blend consisting essentially of a first and second SEEPS copolymer. The first and second SEEPS copolymers are present in the polymer blend in an amount of from 75 to 95 percent by weight and 5 to 25 percent by weight, respectively, based on the total weight of the polymer blend. In addition, the sum of the first and second SEEPS copolymers in the polymer blend is 100 percent by weight. The first and second SEEPS copolymers have a weight average molecular weight of weight of at least 200,000 and 125,000 to 175,000, respectively. The disclosure also provides a patient support for supporting a patient with the patient support formed from the elastomeric composition.

Hydrophilic compositions

A process of forming a cross-linked electronically active hydrophilic co-polymer is provided and includes the steps of: a. mixing an intrinsically electronically active material and at least one compound of formula (I) with water to form an intermediate mixture; b. adding at least one hydrophilic monomer, at least one hydrophobic monomer, and at least one cross-linker to the intermediate mixture to form a co-monomer mixture; and c. polymerising the co-monomer mixture. Formula (I) is defined as: ##STR00001##
where R.sup.1 and R.sup.2 are independently optionally substituted C.sub.1-C.sub.6 alkyl and X.sup.− is an anion.

Hydrophilic compositions

A process of forming a cross-linked electronically active hydrophilic co-polymer is provided and includes the steps of: a. mixing an intrinsically electronically active material and at least one compound of formula (I) with water to form an intermediate mixture; b. adding at least one hydrophilic monomer, at least one hydrophobic monomer, and at least one cross-linker to the intermediate mixture to form a co-monomer mixture; and c. polymerising the co-monomer mixture. Formula (I) is defined as: ##STR00001##
where R.sup.1 and R.sup.2 are independently optionally substituted C.sub.1-C.sub.6 alkyl and X.sup.− is an anion.

Thermoplastic resin composition and molded article manufactured therefrom

A thermoplastic resin composition of the present invention comprises: a polycarbonate resin; a rubber-modified vinyl-based graft copolymer; a large particle size rubbery polymer having an average particle size of about 400 to about 1,500 nm; an aromatic vinyl-based copolymer resin; a phosphorus-based flame retardant; talc; wollastonite; a maleic anhydride grafted rubbery polymer; and a black pigment. The thermoplastic resin composition is superior in terms of adhesion to metal, strength, flame retardancy, fluidity, and appearance.

Thermoplastic resin composition and molded article manufactured therefrom

A thermoplastic resin composition of the present invention comprises: a polycarbonate resin; a rubber-modified vinyl-based graft copolymer; a large particle size rubbery polymer having an average particle size of about 400 to about 1,500 nm; an aromatic vinyl-based copolymer resin; a phosphorus-based flame retardant; talc; wollastonite; a maleic anhydride grafted rubbery polymer; and a black pigment. The thermoplastic resin composition is superior in terms of adhesion to metal, strength, flame retardancy, fluidity, and appearance.

Heat-resistant resin composition

Provided is a heat-resistant resin composition which includes: a graft copolymer prepared by graft polymerization of a diene-based rubber polymer with an aromatic vinyl-based monomer and a vinyl cyan-based monomer; a first styrene-based copolymer including a maleimide-based unit and an aromatic vinyl-based unit; a second styrene-based copolymer including a vinyl cyan-based unit and an aromatic vinyl-based unit; and a third styrene-based copolymer including a vinyl cyan-based unit and an aromatic vinyl-based unit, wherein the second styrene-based copolymer and the third styrene-based copolymer include a vinyl cyan-based unit in mutually different amounts.

Heat-resistant resin composition

Provided is a heat-resistant resin composition which includes: a graft copolymer prepared by graft polymerization of a diene-based rubber polymer with an aromatic vinyl-based monomer and a vinyl cyan-based monomer; a first styrene-based copolymer including a maleimide-based unit and an aromatic vinyl-based unit; a second styrene-based copolymer including a vinyl cyan-based unit and an aromatic vinyl-based unit; and a third styrene-based copolymer including a vinyl cyan-based unit and an aromatic vinyl-based unit, wherein the second styrene-based copolymer and the third styrene-based copolymer include a vinyl cyan-based unit in mutually different amounts.